Biotechnology Research Reports

  Biological Safety Testing Products & Services Industry Overview   The global biological safety testing products & services market size was valued at USD 2.77 billion in 2018 and is expected to grow at a CAGR of 12.3% over the forecast period.  The market is primarily driven by the increasing production of new-generation biologics by major pharmaceutical and biotechnology companies. The high prevalence of target diseases globally has encouraged companies to increase the production of advanced biologics. The rising need for biologics has resulted in unprecedented growth in the number of biopharmaceutical companies. Increasing competition to develop therapeutically advanced drugs on a large scale has compelled manufacturers to improve aspects of manufacturing processes such as productivity and cost-efficiency. Companies are thus implementing good manufacturing practices involving thorough biological testing at various levels of the production cycle, thereby aiding the market gro

In-vitro Toxicology Testing Industry Overview   The global in-vitro toxicology testing market size was estimated at USD 22.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.7% from 2021 to 2028. Significant advancements in toxicology science are one of the primary factors driving the market. Also, high costs associated with conventional animal tests and socio-ethical concerns associated with animal tests are anticipated to boost the growth of the market for in-vitro toxicology testing.  As in-vitro toxicology studies can help in minimizing liabilities related to late-stage failure in the drug discovery process, a high number of research studies and drug development programs for COVID-19 are expected to accelerate the market for in-vitro toxicology testing. More than 590 drugs for COVID-19 are in the development program as of November 2020. Such a high number of drug development programs is anticipated to boost the demand for in vitro toxicology t

Spatial Genomics & Transcriptomics Industry Overview The global spatial genomics and transcriptomics market size was valued at USD 163.8 million in 2020 and is expected to expand at a CAGR of 11.1% from 2021 to 2028. Architecture analysis of genome content in histological specimens is considered a cornerstone in several biomedical research and diagnostics. This is effectively addressed by the advent of spatial omics as a technology-driven field that involves the determination of high-throughput omics data procured from tissue and cell specimens, along with data for the organizational structure of cell content, resulting in the revenue growth of the market. Technologies being introduced in this market are a result of convergence between conventional imaging technologies and novel high-throughput sequencing technologies with methods that help determine positional information of DNAs and RNAs. Although this field holds significant potential in disease management, spatially resolved om